TY - JOUR
T1 - 9-year trend in the management of acute heart failure in Japan
T2 - A report from the national consortium of acute heart failure registries
AU - Shiraishi, Yasuyuki
AU - Kohsaka, Shun
AU - Sato, Naoki
AU - Takano, Teruo
AU - Kitai, Takeshi
AU - Yoshikawa, Tsutomu
AU - Matsue, Yuya
N1 - Funding Information:
This work was supported by the following; ATTEND was supported by the Japanese Heart Foundation (No. 342007). WET-HF was supported by a Grant-in-Aid for Scientific Research (JPSS KAKENHI, 23591062, 26461088, 18K08056; Yoshi-kawa), Health Labour Sciences Research Grant (14528506; Yoshikawa) and the Sakakibara Clinical Research Grant for Promotion of Sciences, 2012, 2013, 2014 (Yoshikawa), a Grant from the Japan Agency for Medical Research and Development (201439013C; Kohsaka). REALITY-AHF was funded by The Cardiovascular Research Fund, Tokyo, Japan.
Funding Information:
Dr Kohsaka received an unrestricted research grant for the Department of Cardiology, Keio University School of Medicine from Bayer Pharmaceutical, and Daiichi Sankyo Co. Ltd and honoraria from Bristol-Myers Squibb and Bayer Pharmaceutical Co. Ltd. Dr Sato has received honoraria from Otsuka, Takeda, Ono, Boehringer Ingelheim, and Daiichi-Sankyo; has received research support from Roche Diagnostics Japan; and has served as a consultant for Terumo, Otsuka, and Bristol-Myers Sqibb. Dr Matsue is affiliated with a department endowed by Philips Respironics, ResMed, Teijin Home Healthcare, and Fukuda Denshi, and received honorarium from Otsuka Pharmaceutical Co. Other authors have no conflicts of interest to disclose.
Publisher Copyright:
© 2018 The Authors.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Background-—Acute heart failure (AHF) is a heterogeneous condition, and its characteristics and management patterns differ by region. Furthermore, limited evidence is available on AHF outside of Western countries. A project by the National Consortium of Acute Heart Failure Registries was designed to evaluate the trends over time in patient backgrounds, in-hospital management patterns, and long-term outcomes of patients with AHF over 9 years in Japan. Methods and Results-—Between 2007 and 2015, registry data for patients with AHF were collected from 3 large-scale quality AHF registries (ATTEND/WET-HF/REALITY-AHF). Predefined end points were trends over time in age, sex, and clinical outcomes, including short- and long-term mortality and readmission for heart failure. The final data set consisted of 9075 patients with AHF. No significant differences in patient backgrounds and laboratory findings (eg, anemia or renal function) were observed, with the exception of patient age; mean age became substantially higher over 9 years (71.6–77.0 years; P for trend, <0.001). On the contrary, length of hospital stay became shorter (mean, 26–16 days). These changes were not associated with in-hospital mortality (4.7–7.5%) or 30-day heart failure readmission rate (4.8–5.4%), as well as 1-year mortality and heart failure readmission rate (20.1– 23.3% and 23.6–26.2%, respectively). Conclusions-—Length of hospital stay in patients with AHF shortened over the 9-year period despite the increasing age of the patients. However, short- and long-term outcomes do not seem to be affected; continuous efforts to monitor clinical outcomes in patients with AHF are needed.
AB - Background-—Acute heart failure (AHF) is a heterogeneous condition, and its characteristics and management patterns differ by region. Furthermore, limited evidence is available on AHF outside of Western countries. A project by the National Consortium of Acute Heart Failure Registries was designed to evaluate the trends over time in patient backgrounds, in-hospital management patterns, and long-term outcomes of patients with AHF over 9 years in Japan. Methods and Results-—Between 2007 and 2015, registry data for patients with AHF were collected from 3 large-scale quality AHF registries (ATTEND/WET-HF/REALITY-AHF). Predefined end points were trends over time in age, sex, and clinical outcomes, including short- and long-term mortality and readmission for heart failure. The final data set consisted of 9075 patients with AHF. No significant differences in patient backgrounds and laboratory findings (eg, anemia or renal function) were observed, with the exception of patient age; mean age became substantially higher over 9 years (71.6–77.0 years; P for trend, <0.001). On the contrary, length of hospital stay became shorter (mean, 26–16 days). These changes were not associated with in-hospital mortality (4.7–7.5%) or 30-day heart failure readmission rate (4.8–5.4%), as well as 1-year mortality and heart failure readmission rate (20.1– 23.3% and 23.6–26.2%, respectively). Conclusions-—Length of hospital stay in patients with AHF shortened over the 9-year period despite the increasing age of the patients. However, short- and long-term outcomes do not seem to be affected; continuous efforts to monitor clinical outcomes in patients with AHF are needed.
KW - Acute heart failure
KW - Japan
KW - Mortality
KW - Readmission
KW - Time trend
UR - http://www.scopus.com/inward/record.url?scp=85055616895&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055616895&partnerID=8YFLogxK
U2 - 10.1161/JAHA.118.008687
DO - 10.1161/JAHA.118.008687
M3 - Article
C2 - 30371201
AN - SCOPUS:85055616895
SN - 2047-9980
VL - 7
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 18
M1 - e008687
ER -